The largest holder of Cigna Group stock is Vanguard Capital Management LLC, with 17.3 million shares (6.54% of the company), worth about $4.77 billion as of September 25, 2026. The 10 largest holders together own 40.2%.
In Q2 2026, 1,781 institutional holdings reports listed shares worth $65.80 billion.
Insiders reported 57 transactions in the last two years: 13 sales worth $90.61 million and 1 purchase. The newest one on file is from September 3, 2026 (Neville Everett, Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 3, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Vanguard Capital Management LLC | 17.3 million | 6.54% | $4.8B |
| BlackRock Advisors LLC | 16.3 million | 6.16% | $4.5B |
| State Street Corporation | 12.7 million | 4.80% | $3.5B |
| Dodge & Cox | 12.2 million | 4.61% | $3.4B |
| MFS Investment Management Canada Ltd. | 10.4 million | 3.95% | $2.9B |
| Sanders Capital LLC | 10.1 million | 3.84% | $2.8B |
| Fidelity Management & Research Co. LLC | 8.0 million | 3.03% | $2.2B |
| BlackRock Life Ltd. | 6.8 million | 2.58% | $1.9B |
| Geode Capital Management LLC | 6.3 million | 2.37% | $1.7B |
| Vanguard Portfolio Management LLC | 6.2 million | 2.36% | $1.7B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,781 | – | $65.8B |
| Q1 2026 | 1,734 | 235.0 million | $62.6B |
| Q4 2025 | 1,732 | 237.0 million | $65.1B |
| Q3 2025 | 1,705 | 240.0 million | $69.2B |
| Q2 2025 | 1,817 | 238.0 million | $78.3B |
| Q1 2025 | 1,771 | 241.0 million | $79.4B |
| Q4 2024 | 1,734 | 244.0 million | $67.3B |
| Q3 2024 | 1,798 | 247.0 million | $85.9B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Neville Everett | Sep 3, 2026 | Officer | Sale at price 284.05 per share. | $175,259 |
| Evanko Brian C | Sep 1, 2026 | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Jones Nicole S. | Aug 18, 2026 | Officer | Sale at price 279.61 per share. | $748,516 |
| Jones Nicole S. | Aug 5, 2026 | Officer | Conversion of Exercise of derivative security at price 192.02 per share. | $2.9M |
| Jones Nicole S. | Aug 4, 2026 | Officer | Sale at price 276.27 per share. | $5.4M |
| Kates Jamie G | Jun 12, 2026 | Officer | Sale at price 298.61 per share. | $268,452 |
| Kates Jamie G | Jun 12, 2026 | Officer | Conversion of Exercise of derivative security at price 152.89 per share. | $137,452 |
| Cordani David M | May 13, 2026 | Chief Executive Officer | Conversion of Exercise of derivative security at price 149.14 - 197.35 per share. | $36.2M |
| Cordani David M | May 12, 2026 | Chief Executive Officer | Sale at price 286.83 - 298.53 per share. | $59.1M |
| Zarcone Donna F | Apr 22, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Foss Eric J. | Apr 22, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Mazzarella Kathleen M. | Apr 22, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 57 insider transactions in the last two years.
Vanguard Capital Management LLC, with 6.54% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.16%) and State Street Corporation (4.80%).
1,781 institutional holdings reports listed Cigna Group shares in Q2 2026 worth $65.80 billion.
In the last two years insiders reported 13 sales and 1 purchase (57 transactions in all); the newest on file is from September 3, 2026.